IL156073A0 - Ion-channel polypeptide and gene, its preparation and use - Google Patents

Ion-channel polypeptide and gene, its preparation and use

Info

Publication number
IL156073A0
IL156073A0 IL15607301A IL15607301A IL156073A0 IL 156073 A0 IL156073 A0 IL 156073A0 IL 15607301 A IL15607301 A IL 15607301A IL 15607301 A IL15607301 A IL 15607301A IL 156073 A0 IL156073 A0 IL 156073A0
Authority
IL
Israel
Prior art keywords
gene
ion
preparation
canion
channel polypeptide
Prior art date
Application number
IL15607301A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL156073A0 publication Critical patent/IL156073A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Plant Pathology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15607301A 2000-12-05 2001-12-04 Ion-channel polypeptide and gene, its preparation and use IL156073A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25131700P 2000-12-05 2000-12-05
PCT/IB2001/002798 WO2002046404A2 (en) 2000-12-05 2001-12-04 Schizophrenia-related voltage-gated ion channel gene and protein

Publications (1)

Publication Number Publication Date
IL156073A0 true IL156073A0 (en) 2003-12-23

Family

ID=22951418

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15607301A IL156073A0 (en) 2000-12-05 2001-12-04 Ion-channel polypeptide and gene, its preparation and use

Country Status (16)

Country Link
US (2) US20040091497A1 (xx)
EP (1) EP1339840B1 (xx)
JP (1) JP2004525614A (xx)
KR (1) KR20030074643A (xx)
CN (1) CN1777676A (xx)
AT (1) ATE339500T1 (xx)
AU (2) AU3357302A (xx)
BR (1) BR0115937A (xx)
CA (1) CA2430712A1 (xx)
DE (1) DE60123109T2 (xx)
EA (2) EA008252B1 (xx)
ES (1) ES2271092T3 (xx)
IL (1) IL156073A0 (xx)
MX (1) MXPA03005069A (xx)
UA (1) UA79927C2 (xx)
WO (1) WO2002046404A2 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042100A1 (en) * 2000-07-03 2002-04-11 Chunhua Yan Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof
WO2002101035A1 (fr) * 2001-05-10 2002-12-19 Mochida Pharmaceutical Co., Ltd. Proteine du canal cation dependant du potentiel
US7634363B2 (en) 2005-12-07 2009-12-15 Affymetrix, Inc. Methods for high throughput genotyping
GB2449819A (en) * 2006-02-28 2008-12-03 Univ California Genes differentially expressed in bipolar disorder and/or schizophrenia
FR2906532B1 (fr) * 2006-09-28 2008-12-12 Biomerieux Sa Nouvel oligonucleotide marque
EP3207051A4 (en) * 2014-10-13 2018-02-28 Dow AgroSciences LLC Copi coatomer alpha subunit nucleic acid molecules that confer resistance to coleopteran and hemipteran pests
KR20210087830A (ko) * 2020-01-03 2021-07-13 삼성전자주식회사 기판 적층 구조를 포함하는 전자 장치
CN114982679B (zh) * 2022-07-22 2023-08-01 中国水产科学研究院长江水产研究所 一种黄鳝家系建立及优良家系选育方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008001A (en) * 1993-11-05 1999-12-28 Yeda Research And Development Co. Ltd. Diagnosis of the susceptibility of contracting schizophrenia
CA2298474A1 (en) * 1997-07-22 1999-02-04 Millenium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
AU760309B2 (en) * 1997-12-03 2003-05-15 Merck & Co., Inc. Low-voltage activated calcium channel compositions and methods
WO1999057316A1 (en) * 1998-04-30 1999-11-11 Institut Pasteur A highly conserved polynucleotide sequence linked to a genetic predisposition to schizophrenia, a method of diagnosis, and applications thereof
JP2002518010A (ja) * 1998-06-16 2002-06-25 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 94個のヒト分泌タンパク質
WO2000022122A2 (en) * 1998-10-13 2000-04-20 Genset Genes, proteins and biallelic markers related to central nervous system disease
WO2000058510A2 (en) * 1999-03-30 2000-10-05 Genset Schizophrenia associated genes, proteins and biallelic markers
EP1280902A2 (en) * 2000-04-29 2003-02-05 Millennium Pharmaceuticals, Inc. 23949 and 32391, human ion channels and uses thereof
CA2415808A1 (en) * 2000-07-07 2002-01-17 Incyte Genomics, Inc. Transporters and ion channels

Also Published As

Publication number Publication date
MXPA03005069A (es) 2003-09-05
EA008252B1 (ru) 2007-04-27
WO2002046404A3 (en) 2002-12-12
CA2430712A1 (en) 2002-06-13
ATE339500T1 (de) 2006-10-15
US20080184381A1 (en) 2008-07-31
EA200300642A1 (ru) 2003-12-25
CN1777676A (zh) 2006-05-24
UA79927C2 (en) 2007-08-10
US20040091497A1 (en) 2004-05-13
WO2002046404A9 (en) 2002-08-15
AU3357302A (en) 2002-06-18
WO2002046404A2 (en) 2002-06-13
DE60123109D1 (de) 2006-10-26
KR20030074643A (ko) 2003-09-19
ES2271092T3 (es) 2007-04-16
EP1339840B1 (en) 2006-09-13
EP1339840A2 (en) 2003-09-03
AU2002233573B2 (en) 2007-03-01
BR0115937A (pt) 2003-09-30
JP2004525614A (ja) 2004-08-26
EA200500974A1 (ru) 2006-02-24
DE60123109T2 (de) 2007-05-16
EA006367B1 (ru) 2005-12-29

Similar Documents

Publication Publication Date Title
EP2284189A3 (en) Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides
DE69633664D1 (de) Genetische marker für brust und eierstockkrebs
EP0837131A3 (en) Staphylococcus fibronectin binding protein compounds
DK1378571T3 (da) 5' ESTs for sekreterede proteiner udtrykt i forskellige væv
WO1999047669A3 (de) Menschliche nukleinsäuresequenzen aus brusttumorgewebe
WO2004035806A3 (en) Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
WO2001070977A3 (en) Fibroblast growth factor receptor-like molecules and uses thereof
WO2001061007A3 (en) Fibroblast growth factor-23 molecules and uses thereof
NZ531570A (en) DNA sequences for human angiogenesis genes
IL156073A0 (en) Ion-channel polypeptide and gene, its preparation and use
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
NZ504445A (en) Nucleic acid sequences of genes of the high mobility group proteins and their use in treating tumours, vascular disorders and as a contraceptive
IL154298A0 (en) Papap proteins, their preparation and use
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO2000058510A3 (en) Schizophrenia associated genes, proteins and biallelic markers
AU2001233957A1 (en) Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (bad) and unipolar depression
NZ518458A (en) Isolate DNA polymerase lambda and uses thereof
WO2002000872A3 (fr) Compositions et methodes pour le traitement ou la detection de pathologies neurodegeneratives
DE69730967D1 (en) Human dnase ii
CN109868306A (zh) 一种cyp2c19基因的快速扩增试剂盒及扩增方法
ATE328082T1 (de) Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen
WO2001040493A3 (en) Schizophrenia associated gene, proteins and biallelic markers
WO2003089613A3 (en) Tocopherol associated protein and uses thereof
EP0839910A3 (en) Spo-rel, a Staphylococcus relA/spot homologue
DE60027419D1 (de) Regulatorische Sequenzen des humanen MCP-1 Gens